A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2004
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259817 Methods and formulations for the treatment of female sexual dysfunction
12/23/2004	US20040259787 C1q and collectin receptor
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259763 Bifunctional agents possessing antioxidant and antiarrhythmic activity
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment
12/23/2004	US20040259156 Bispecific immunoglobulin-like antigen binding proteins and method of production
12/23/2004	US20040259150 Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040258782 Isolation of lutein from alfalfa
12/23/2004	US20040258777 Aqueous topical solutions stimulate endothelial growth factors and microcirculation; solvent extraction with volatile non-aqueous solvents; obestity; reduction of cellulite and localized dermal adipose deposits
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258745 Pharmaceutical composition containing artificial oxygen carrier
12/23/2004	US20040258692 Method for the treatment of cardiotoxicity induced by antitumor compounds
12/23/2004	US20040258680 Methos of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogoues, isoforms and other derivatives
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258619 Diaminedioxime radiometal complexes
12/23/2004	US20040255959 Method and compounds to decrease the incidence of atrial fibrillation (AF) in patients with left ventricular dysfunction
12/23/2004	US20040255956 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
12/23/2004	DE10325049A1 New peptide derivatives containing cell-adhesion molecule and phosphonate-containing anchor component, useful for treating disorders associated with implants, are inhibitors of integrins
12/23/2004	DE10308355A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments
12/23/2004	CA2529478A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2528382A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them
12/23/2004	CA2528367A1 A1 adenosine receptor antagonists
12/23/2004	CA2527246A1 Aniline derivatives
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/22/2004	EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
12/22/2004	EP1489172A1 Nuclear receptor err gamma 3
12/22/2004	EP1489096A1 Novel hemepeptide
12/22/2004	EP1489091A1 Process for producing triterpene derivative
12/22/2004	EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
12/22/2004	EP1489076A1 Cyclic hemiacetal derivative and use thereof
12/22/2004	EP1488806A2 A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488801A1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases
12/22/2004	EP1488793A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
12/22/2004	EP1488761A1 Device for delivering a therapeutic agent to a blood vessel
12/22/2004	EP1487876A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/22/2004	EP1487874A1 Falp proteins
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487836A1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
12/22/2004	EP1487834A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
12/22/2004	EP1487831A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487829A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487792A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487776A1 Acid and ester compounds and methods of using the same
12/22/2004	EP1487774A2 Bipolar trans carotenoid salts and their uses
12/22/2004	EP1487541A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/22/2004	EP1487540A2 Storage stable eplerenone formulation
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487478A2 Interferon beta-like molecules for treatment of stroke
12/22/2004	EP1487476A1 Use of angiotensin 1-7 for enhancing cardiac function
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487443A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487436A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers
12/22/2004	EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487424A2 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
12/22/2004	EP1487273A1 Compositions and methods for treatment of microbial infections
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1453949A4 Production of cell suspensions
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1363656B1 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
12/22/2004	EP1355635B1 New film coating
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1311284B1 Saratin for inhibiting platelet adhesion to collagen
12/22/2004	EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity
12/22/2004	EP1226230B1 Lactobacillus helveticus producing antihypertensive di- and tripeptides
12/22/2004	EP1189907B1 Thienopyrimidines as phosphodiesterase inhibitors
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

1 ... 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 ... 1595